Search Within

Elaine Duck

Formats
  1. Meeting Abstract (9)
  2. Journal Article (8)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (15)
  2. Department of Medicine (14)
  3. Population Sciences Research Program (13)
  4. Nursing (11)
  5. Solid Tumor Oncology Division (9)
  6. Health Outcomes Research Group (8)

More Groups

People
  1. Peter Bach (8)
  2. Mark Radzyner (6)
  3. Sergio Giralt (6)
  4. David Rubin (5)
  5. Katherine Panageas (5)
  6. Miguel-Angel Perales (4)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (4)
  5. 2018 (2)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Blood (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Bone Marrow Transplantation (2)
  5. JCO Oncology Practice (2)
  6. Inquiry: The Journal of Health Care Organization Provision and Financing (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Society of Hematology (3)
  3. Elsevier Inc. (2)
  4. Elsevier Science, Inc. (2)
  5. Nature Publishing Group (2)
  6. AME Publishing Company (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Progress towards value in healthcare: Implementation of Time-Driven Activity-Based Costing (TDABC) in hematopoietic stem cell transplantation
    Meeting Abstract

    Vanak, J. M.; Cheavers, C.; Duggan, E.; Duck, E.; Radzyner, M.; Nelson, P.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage
    Journal Article

    Pfister, D. G.; Rubin, D. M.; Elkin, E. B.; Neill, U. S.; Duck, E.; Radzyner, M.; Bach, P. B.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Cost analysis of using plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Adel, N. G.; Duck, E.; Collum, K.; Mccullagh, E.; Reich, L.; Landau, H.; Giralt, S.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients
    Journal Article

    Mathew, S.; Adel, N.; Rice, R. D.; Panageas, K.; Duck, E. T.; Comenzo, R. L.; Kewalramani, T.; Nimer, S. D.
    Bone Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Productivity vs. training in primary care: Analysis of hospitals and health centers in New York City
    Journal Article

    DeLia, D.; Cantor, J. C.; Duck, E.
    Inquiry: The Journal of Health Care Organization Provision and Financing (2002)

    Fulltext@MSK | Save
  • Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer
    Journal Article

    Modi, S.; Panageas, K. S.; Duck, E. T.; Bach, A.; Weinstock, N.; Dougherty, J.; Cramer, L.; Hudis, C.; Norton, L.; Seidman, A.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save